News

French writer-director Laura Piani’s romantic comedy starring Camille Rutherford will now open in select theaters on May 23, before going wide a week later. By Etan Vlessing Canada Bureau Chief ...
This was on the basis that damages would be an adequate remedy for AZ in the event that the SPC was held valid and therefore infringed, whereas damages would not be an adequate remedy for Glenmark ...
Patients with a rare disease called mucous membrane pemphigoid are at risk of developing squamous cell carcinoma and basal cell carcinoma, finds a new study. Patients with mucous membrane pemphigoid ...
Investigators assessed silmitasertib monotherapy in patients who had failed first-line hedgehog pathway inhibitors, with 27.3% also failing second-line PD-1 inhibitors such as cemiplimab (Libtayo) or ...
Therefore, Senhwa will actively pursue licensing possibilities while carefully evaluating CX-4945's potential as a monotherapy or in combination with the second-line immunotherapy Libtayo. The company ...
Therefore, Senhwa will actively pursue licensing possibilities while carefully evaluating CX-4945's potential as a monotherapy or in combination with the second-line immunotherapy Libtayo.
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...
It’s hard to green the desert. Take China, or Africa’s Sahel region, for example. Their “Great Green Walls,” grand projects to beat back encroaching desert by planting trees, have required ...
and efficacy of solnerstotug as both a monotherapy and in combination with Regeneron’s PD-1 inhibitor Libtayo ® (cemiplimab) in patients with advanced solid tumors. Recent updates include ...
One patient with Merkel cell carcinoma (MCC) achieved a durable complete response with 15 milligrams per kilogram (mg/kg) solnerstotug and Libtayo (cemiplimab) and remains on treatment at 42 or more ...